UTI Dual Advantage Fixed Term Fund Series III II (1278 Days) Direct Growth

UTI Dual Advantage Fixed Term Fund Series III II (1278 Days) Direct Growth

Debt
Marginal Equity
Moderately High Risk
+4.35%
3Y annualised
+0.01% 1D
1M
6M
1Y
3Y
All
NAV: 07 Jan '20
₹11.94
Min. SIP amount
Not Supported
Fund size
₹64.79 Cr
Expense ratio
0.00%

Holdings (41)

NameSectorInstrumentsAssets
UTI Liquid Cash Direct-GrowthFinancialMutual Fund16.54%
Hero FinCorp Ltd.FinancialDebenture10.30%
ONGC Mangalore Petrochemicals LtdChemicalsDebenture9.83%
L&T Infrastructure Finance Co. Ltd.FinancialDebenture8.11%
Power Grid Corporation of India Ltd.EnergyBonds7.37%
Tata Power Company Ltd.EnergyNCD7.37%
Dewan Housing Finance Corporation Ltd.FinancialDebenture7.37%
REC Ltd.FinancialBonds7.36%
Steel Authority Of India Ltd.MetalsBonds7.33%
ICICI Bank Ltd.FinancialEquity2.03%
HDFC Bank Ltd.FinancialEquity1.93%
HDFC Bank Ltd.FinancialEquity1.74%
ICICI Bank Ltd.FinancialEquity1.59%
Coforge Ltd.TechnologyEquity1.40%
Infosys Ltd.TechnologyEquity1.23%
Infosys Ltd.TechnologyEquity1.22%
GAIL (India) Ltd.EnergyEquity0.90%
Mphasis Ltd.TechnologyEquity0.72%
GAIL (India) Ltd.EnergyEquity0.66%
Torrent Power Ltd.EnergyEquity0.60%
Sun Pharmaceutical Industries Ltd.HealthcareEquity0.58%
Mahindra & Mahindra Ltd.AutomobileEquity0.52%
MRF Ltd.AutomobileEquity0.48%
Procter & Gamble Hygiene & Health Care Ltd.FMCGEquity0.41%
Tata Consumer Products Ltd.FMCGEquity0.40%
HCL Technologies Ltd.TechnologyEquity0.37%
HCL Technologies Ltd.TechnologyEquity0.34%
NTPC Ltd.EnergyEquity0.34%
Oracle Financial Services Software Ltd.TechnologyEquity0.33%
NIIT Ltd.TechnologyEquity0.33%
Exide Industries Ltd.EngineeringEquity0.30%
Sun TV Network Ltd.ServicesEquity0.29%
Exide Industries Ltd.EngineeringEquity0.29%
GHCL Ltd.ChemicalsEquity0.28%
Aurobindo Pharma Ltd.HealthcareEquity0.26%
GHCL Ltd.ChemicalsEquity0.23%
Cadila Healthcare Ltd.HealthcareEquity0.18%
Aurobindo Pharma Ltd.HealthcareEquity0.18%
Cadila Healthcare Ltd.HealthcareEquity0.17%
REC Ltd.FinancialBonds0.15%
The Federal Bank Ltd.FinancialST Dep.0.00%
See All

Minimum investments

Min. for 1st investment
Not Supported
Min. for 2nd investment
Not Supported
Min. for SIP
Not Supported

Returns and rankings

Annualised returns
Absolute returns
Name6M1Y3YAll
Fund returns+3.0%-1.5%+4.3%+5.2%
Category average (Debt Marginal Equity)+6.8%+8.8%+15.1%--
Rank (Debt Marginal Equity)--7534--

Exit load, stamp duty and tax

Exit load

Nil

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

Returns are taxed as per your Income Tax slab.
Check past data

About UTI Dual Advantage Fixed Term Fund Series III II (1278 Days) Direct Growth

UTI Dual Advantage Fixed Term Fund Series III II (1278 Days) Direct Growth is a Debt Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 14 Nov 2002. The fund currently has an Asset Under Management(AUM) of ₹3,94,217 Cr and the Latest NAV as of 07 Jan 2020 is ₹11.94. The UTI Dual Advantage Fixed Term Fund Series III II (1278 Days) Direct Growth is rated Moderately High risk. ;

Investment Objective

The scheme seeks to generate income and reduce interest rate volatility by investing in fixed income securities that are maturing on or before the date of maturity of the Scheme and generate capital appreciation by investing in equity and equity related instruments.
Fund benchmarkCRISIL Hybrid 85+15 Conservative Index

Fund house

Rank (total assets)#8 in India
Total AUM₹3,94,217.41 Cr
Date of Incorporation14 Nov 2002
Phone0263 2296993
E-mailNA
Launch Date14 Nov 2002
AddressUTI Tower, Plot C-1, GN Block,Banrda Kurla Complex, Bandra (East) Mumbai 400051
CustodianNA
Registrar & Transfer AgentKFin Tech
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,